Unlock Cell Therapy Potential with Customizable Cell Isolation and Enhanced T cell Activation Solution

Cell isolation and activation are critical for cell therapy development and manufacturing. Ease of use, regulatory compliant and financial sustainability are among the most important considerations. Current options are hard to meet all the requirements and put limitation on cell therapy development.

In this webinar, we’ll introduce how GenScript’s Cytosinct™ Cell Isolation Nanobeads Customization Service and Enceed™ T Cell Activation Reagent empower researchers and developers to achieve optimal performance across diverse therapeutic workflows.

The Cytosinct™ customizable nanobead platform offers tailored solutions for isolating specific immune cell subsets with high purity and viability, while supporting various magnetic separation systems. Through surface marker flexibility and scalable production, GenScript enables seamless integration into both research and GMP-compliant processes.

Complementing this, the Enceed™ T Cell Activation Reagent provides a robust and reproducible way to activate and expand T cells — delivering strong activation signals with minimal variability to support downstream applications such as CAR-T manufacturing and immunological research. 

Join our experts to explore how these innovative tools can help enhance yield, consistency, and customization in your cell therapy development pipeline.

Learning Objectives: 

1. How robotics radically improves the unit economics of cell therapy manufacturing, increasing throughput, and accelerating timelines?

2. How the robotic system overcomes potential regulatory and process barriers by operating market-leading GMP instruments that are already deployed?

3. How can cell isolation be robotic automated utilizing GenScript CytoSinct and Multiply lab platform?